Verve Therapeutics
VERV
$6.16
Share price
-0.96%
Change (1 day)
-60.86%
Change (1 year)
Verve Therapeutics (VERV) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.15 B
According to Verve Therapeutics's latest financial reports the company's total liabilities are $0.15 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Verve Therapeutics - Total liabilities on balance sheet (from 2020 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.15 B | 19.41% |
| 2022-12-31 | $0.12 B | 379.2% |
| 2021-12-31 | $26.77 M | -81.19% |
| 2020-12-31 | $0.14 B | 245.44% |
| 2019-12-31 | $41.2 M |